Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/16/2025

Management of Urinary Tract Infections and Bacterial Vaginosis

Diagnosis and Evaluation

  • The Centers for Disease Control and Prevention (CDC) recommends assessing for clinical criteria for BV, including homogeneous, white discharge adhering to vaginal walls, presence of clue cells on microscopic examination, vaginal fluid pH > 4.5, and fishy odor before or after addition of 10% KOH (whiff test), with at least 3 of the 4 criteria required for diagnosis 1
  • For UTI, evaluation of symptoms (dysuria, frequency, urgency) and obtaining urine culture is recommended 1

Treatment

  • The CDC recommends first-line treatment for BV with Metronidazole 500 mg orally twice daily for 7 days, with alternative options including Metronidazole 2g orally in a single dose, Clindamycin cream 2%, and Metronidazole gel 0.75% 1
  • For UTI, common first-line options include Nitrofurantoin 100 mg twice daily for 5 days, Fosfomycin 3g single dose, and Cephalexin 500 mg four times daily for 5-7 days, with selection based on local resistance patterns and patient factors 2
  • The CDC recommends avoiding alcohol during metronidazole treatment and for 24 hours afterward 1
  • Consideration of pregnancy status is essential when selecting antibiotics, with oral metronidazole or clindamycin preferred for BV in pregnancy, and nitrofurantoin or cephalexin recommended as first-line options for UTI in pregnancy 3
  • Trimethoprim-sulfamethoxazole should be avoided in the first and third trimesters of pregnancy 3

Prevention and Recurrence

  • Increased fluid intake and good urogenital hygiene are recommended to prevent recurrence of UTI and BV 3
  • Consideration of probiotics containing Lactobacillus species may help restore normal vaginal flora and prevent recurrent BV 3
  • Postcoital prophylaxis with nitrofurantoin or cephalexin may be considered for recurrent UTI 3

Common Pitfalls

  • Treating only one condition may lead to persistent symptoms and complications, and inadequate treatment duration, particularly for BV, has lower cure rates 1
  • Ignoring male partners may be a consideration in recurrent cases, although treatment of male partners has not been proven to prevent BV recurrence 1
  • Missing follow-up and ensuring patients understand the importance of completing the full course of treatment for both conditions is crucial 1